TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225. January 4, 2002